This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C,-80 °C
Storage Comment
Store at 2°C to 8°C for 1 week. For long term storage, aliquot and store at -20°C to -80°C. Aliquot to avoid repeated freezing and thawing.
Tagliabracci, Turnbull, Wang, Girard, Zhao, Skurat, Delgado-Escueta, Minassian, Depaoli-Roach, Roach: "Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, Issue 49, pp. 19262-6, (2007) (PubMed).
Wang, Parker, Skurat, Raben, DePaoli-Roach, Roach: "Relationship between glycogen accumulation and the laforin dual specificity phosphatase." in: Biochemical and biophysical research communications, Vol. 350, Issue 3, pp. 588-92, (2006) (PubMed).
Ganesh, Delgado-Escueta, Suzuki, Francheschetti, Riggio, Avanzini, Rabinowicz, Bohlega, Bailey, Alonso, Rasmussen, Thomson, Ochoa, Prado, Medina, Yamakawa: "Genotype-phenotype correlations for EPM2A mutations in Lafora's progressive myoclonus epilepsy: exon 1 mutations associate with an early-onset cognitive deficit subphenotype." in: Human molecular genetics, Vol. 11, Issue 11, pp. 1263-71, (2002) (PubMed).
Target
EPM2A
(Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A))